Index
S&P 500
Market Cap
22.63B
Enterprise Value
24.21B
Income
805.20M
Sales
6.04B
Book/sh
73.91
Cash/sh
4.95
Employees
17937
IPO
Jun 01, 1992
P/E
28.37
Forward P/E
18.93
PEG
1.95
P/S
3.75
P/B
3.14
P/C
46.93
P/FCF
24.45
EV/EBITDA
14.45
EV/Sales
4.01
Quick Ratio
1.35
Current Ratio
1.91
Debt/Eq
0.28
LT Debt/Eq
0.24
Option/Short
Yes / Yes
EPS (ttm)
8.18
EPS next Y
12.26
EPS next Q
2.68
EPS this Y
10.27%
EPS next Y
9.35%
EPS next 5Y
9.69%
EPS past 3/5Y
95.07% 11.37%
Sales past 3/5Y
9.38% 13.82%
EPS Y/Y TTM
23.94%
Sales Y/Y TTM
8.37%
EPS Q/Q
13.83%
Sales Q/Q
7.30%
Insider Own
0.34%
Insider Trans
-3.32%
Inst Own
100.51%
Inst Trans
-0.11%
ROA
7.62%
ROE
11.37%
ROIC
8.97%
Gross Margin
45.00%
Oper. Margin
19.61%
Profit Margin
13.34%
SMA20
5.12%
SMA50
5.52%
SMA200
3.21%
Trades
Shs Outstand
97.50M
Shs Float
97.17M
52W High
269.44 -13.84%
52W Low
195.14 18.96%
Volatility
2.53% 2.22%
ATR (14)
4.93
RSI (14)
65.78
Beta
0.88
Rel Volume
0.70
Avg Volume
691.26K
Volume
485,902
Perf Week
-0.03%
Perf Month
10.54%
Perf Quarter
1.64%
Perf Half Y
7.04%
Perf YTD
-8.43%
Perf Year
-1.96%
Perf 3Y
10.86%
Perf 5Y
-0.68%
Perf 10Y
246.89%
Prev Close
228.78
Price
232.14
Change %
1.47%
Analysts 13 incl. previous ratings
Rating Distribution 8 Buy · 5 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jul 28, 2026 Initiated U UBS
Buy $275 +18.5% Jul 15, 2025 Upgrade M Morgan Stanley
Equal-Weight → Overweight $276 +18.9% May 29, 2025 Initiated J Jefferies
Hold $263 +13.3% Oct 24, 2024 Upgrade P Piper Sandler
Neutral → Overweight $230 → $260 +12.0% Feb 06, 2024 Resumed K KeyBanc Capital Markets
Overweight $253 +9.0% May 30, 2023 Initiated M Morgan Stanley
Equal-Weight $206 -11.3% Apr 14, 2023 Downgrade P Piper Sandler
Overweight → Neutral $215 → $197 -15.1% Sep 23, 2022 Downgrade N Needham
Buy → Hold Jul 14, 2022 Initiated P Piper Sandler
Overweight $240 +3.4% Apr 07, 2022 Initiated W Wolfe Research
Outperform $275 +18.5% May 26, 2021 Upgrade N Needham
Hold → Buy $233 +0.4% Feb 04, 2021 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight Sep 02, 2020 Initiated R Robert W. Baird
Outperform $175 -24.6% Jun 09, 2020 Initiated N Needham
Hold Jul 10, 2019 Downgrade K KeyBanc Capital Markets
Overweight → Sector Weight Jan 03, 2018 Downgrade R Raymond James
Outperform → Mkt Perform Jun 05, 2017 Downgrade W Wellington Shields
Gradually Accumulate → Hold May 03, 2017 Upgrade K KeyBanc Capital Mkts
Sector Weight → Overweight Nov 30, 2016 Initiated G Goldman
Neutral $71 -69.4% Jun 03, 2016 Upgrade N Northcoast
Neutral → Buy
Show Previous Ratings
Today 07:03AM
(The Sanford Herald, N.C.)
Oct-28-26 04:30PM
Oct-27-26 08:14PM
Oct-20-26 04:30PM
Oct-13-26 10:00AM
08:41AM
Loading…
08:41AM
Oct-12-26 02:43PM
09:11AM
(The Wall Street Journal)
08:00AM
Sep-01-26 04:30PM
Aug-06-26 07:57AM
07:00AM
(The Sanford Herald, N.C.)
Aug-05-26 04:44PM
04:30PM
08:45AM
04:30PM
Loading…
Jul-30-26 04:30PM
Jul-27-26 04:30PM
May-12-26 07:01PM
04:30PM
May-11-26 04:52PM
04:30PM
May-07-26 04:30PM
May-05-26 04:30PM
Apr-21-26 04:30PM
Apr-09-26 06:30AM
Mar-16-26 03:40AM
Mar-06-26 11:30AM
Mar-05-26 08:41AM
Feb-20-26 07:27AM
Feb-15-26 06:53AM
12:35AM
Loading…
Feb-11-26 12:35AM
Feb-09-26 09:15AM
Feb-07-26 01:13AM
Feb-05-26 07:46PM
(Morningstar Research)
-7.74%
04:00PM
09:25AM
Feb-04-26 06:00PM
05:40PM
04:54PM
04:39PM
(Associated Press Finance)
04:30PM
11:55AM
Feb-03-26 10:29AM
08:29AM
Feb-02-26 10:17PM
09:51AM
Jan-30-26 12:07PM
Jan-29-26 12:47PM
Jan-28-26 04:30PM
12:35PM
12:31PM
07:26AM
Jan-27-26 11:47AM
Jan-23-26 11:43AM
Jan-22-26 12:32PM
Jan-21-26 04:30PM
10:49AM
07:58AM
Jan-20-26 04:30PM
Jan-19-26 12:34PM
12:31PM
Jan-16-26 09:27AM
Jan-15-26 10:37AM
10:35AM
08:24AM
Jan-14-26 10:31PM
10:48AM
10:44AM
Jan-12-26 08:09AM
Jan-09-26 09:08AM
Jan-08-26 06:02AM
Dec-26-25 12:00PM
Dec-16-25 09:45AM
Dec-10-25 07:57AM
Dec-09-25 11:47AM
11:32AM
Dec-05-25 11:30AM
Dec-04-25 08:27AM
Dec-03-25 11:03PM
Nov-20-25 12:00PM
09:11AM
Nov-10-25 09:15AM
Nov-07-25 09:37PM
Nov-06-25 04:15PM
11:37AM
08:29AM
Nov-05-25 07:00PM
05:50PM
05:04PM
04:51PM
(Associated Press Finance)
04:30PM
Nov-04-25 06:05PM
09:15AM
Nov-03-25 10:04PM
Oct-30-25 05:10PM
Oct-29-25 04:30PM
Oct-23-25 11:56AM
12:01AM
Oct-22-25 08:40AM
04:39AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Breeden Richard C Director Aug 18 '26 Proposed Sale 231.90 4,110 953,114 Aug 18 05:25 PM Sohi Mohsen Director Aug 12 '26 Option Exercise 86.23 4,058 349,921 28,363 Aug 12 04:33 PM Sohi Mohsen Director Aug 12 '26 Sale 235.78 4,058 956,795 24,305 Aug 12 04:33 PM Sohi Mohsen Director Aug 12 '26 Proposed Sale 235.78 4,058 956,779 Aug 12 04:06 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Jun 15 '26 Sale 209.28 1,419 296,968 35,259 Jun 16 04:31 PM Zangerle John Adam Officer Jun 15 '26 Proposed Sale 209.28 1,419 296,968 Jun 15 04:06 PM Carestio Daniel A President and CEO Jun 04 '26 Sale 214.64 3,054 655,511 65,021 Jun 08 04:31 PM Carestio Daniel A President and CEO Jun 05 '26 Sale 212.00 1,374 291,288 63,647 Jun 08 04:31 PM Carestio Daniel A Officer Jun 05 '26 Proposed Sale 212.00 1,374 291,288 Jun 05 04:06 PM Breeden Richard C Director Jun 02 '26 Option Exercise 71.40 3,781 269,963 40,445 Jun 04 04:31 PM Breeden Richard C Director Jun 02 '26 Sale 209.51 1,481 310,284 38,964 Jun 04 04:31 PM Carestio Daniel A Officer Jun 04 '26 Proposed Sale 214.64 3,054 655,511 Jun 04 04:13 PM Breeden Richard C Director Jun 02 '26 Proposed Sale 209.51 1,481 310,285 Jun 02 04:18 PM FELDMANN CYNTHIA L Director Mar 05 '26 Option Exercise 152.32 3,098 471,887 3,803 Mar 06 04:32 PM FELDMANN CYNTHIA L Director Mar 05 '26 Sale 237.21 3,098 734,877 705 Mar 06 04:32 PM FELDMANN CYNTHIA L Director Mar 05 '26 Proposed Sale 237.21 3,098 734,867 Mar 05 04:04 PM Madsen Julia Sr. VP and GM, Life Sciences Nov 21 '25 Option Exercise 128.22 5,008 642,139 13,582 Nov 25 04:39 PM Madsen Julia Sr. VP and GM, Life Sciences Nov 21 '25 Sale 262.00 5,008 1,312,096 10,710 Nov 25 04:39 PM Madsen Julia Officer Nov 21 '25 Proposed Sale 262.00 5,008 1,312,096 Nov 21 04:51 PM Tamaro Renato V.P. & Corporate Treasurer Nov 18 '25 Option Exercise 182.22 3,536 644,330 10,731 Nov 20 04:31 PM Tamaro Renato V.P. & Corporate Treasurer Nov 18 '25 Sale 257.55 5,036 1,297,040 5,695 Nov 20 04:31 PM Tamaro Renato Officer Nov 18 '25 Proposed Sale 257.55 5,036 1,297,033 Nov 18 04:46 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Nov 11 '25 Option Exercise 69.72 15,000 1,045,800 48,669 Nov 13 04:34 PM Zangerle John Adam Sr. VP, Gen Counsel, and Sec. Nov 11 '25 Sale 265.14 15,000 3,977,100 33,669 Nov 13 04:34 PM Zangerle John Adam Officer Nov 11 '25 Proposed Sale 265.14 15,000 3,977,050 Nov 12 01:26 PM
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
President Mr. Daniel A. Carestio
Senior VP Ms. Karen L. Burton
Senior VP Mr. John Adam Zangerle
SVP & Chief Human Resources Officer Ms. Mary Clare Fraser
Senior VP & President of Healthcare Mr. Cary L. Majors